Enanta Pharmaceuticals, Inc.ENTANASDAQ
Loading
Interest Income Over TimeStrong
Percentile Rank80
3Y CAGR-7.1%
5Y CAGR+35.1%
Year-over-Year Change
Income earned from interest-bearing assets
3Y CAGR
-7.1%/yr
vs +6.5%/yr prior
5Y CAGR
+35.1%/yr
Recent deceleration
Acceleration
-13.6pp
Decelerating
Percentile
P80
Within normal range
vs 5Y Ago
4.5x
Strong expansion
Streak
2 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $9.10M | -4.0% |
| 2025 | $9.48M | -35.8% |
| 2024 | $14.77M | +30.0% |
| 2023 | $11.36M | +622.2% |
| 2022 | $1.57M | -22.2% |
| 2021 | $2.02M | -68.8% |
| 2020 | $6.47M | -26.6% |
| 2019 | $8.82M | - |
| 2018 | $0.00 | -100.0% |
| 2017 | $2.53M | - |